Form 4 · Filed Jul 1, 2026, 10:49 PM UTC
LXEO/Lexeo Therapeutics, Inc.
Tamayo Louis Edward — Chief Financial Officer
AI Thesis
A thesis has not been generated for this filing yet — usually available within 60 seconds of EDGAR publication. Refresh shortly.
Research signal, not investment advice. Form 4 AI surfaces SEC filings and applies an analytical layer — it does not predict prices or recommend trades. Past performance does not guarantee future results. See methodology and public track record for how scores are computed.
Transactions
2 rows| Date | Code | Direction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| Jul 1, 2026 | S | sell | 4,641 | $4 | $20,838 | 97,024 |
| Jun 29, 2026 | A | other | 12,000 | $0 | — | 101,665 |
Source: SEC EDGAR raw filing ↗ · Accession 0002083206-26-000005